Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study.


Journal

Virulence
ISSN: 2150-5608
Titre abrégé: Virulence
Pays: United States
ID NLM: 101531386

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 30 7 2020
medline: 28 8 2020
entrez: 30 7 2020
Statut: ppublish

Résumé

Novel coronavirus disease 2019 (COVID-19), caused by novel coronavirus SARS-CoV-2, has spread globally since the end of 2019. Asymptomatic carriers are of great concern as they can undermine the interventions to stop the pandemic. However, there is limited information about the characteristics and outcomes of the asymptomatic patients. Therefore, we conducted this retrospective study and retrieved data of 79 asymptomatic COVID-19 patients at admission from three designated hospitals in Wuhan, China. The asymptomatic patients could happen at any age, ranged from 9 to 96 years. These patients also had lower levels of alanine aminotransferase and C-reactive protein. Patchy shadowing was the most common manifestation in computed tomography scan. Some asymptomatic carriers developed mild or moderate symptoms during hospitalization. Age and comorbidities, especially hypertension, may be predictive factors for symptom development in the initially asymptomatic carriers at admission. Early detection and treatment for these presymptomatic patients before symptom onset can shorten the communicable period for the coronavirus and reduce the occurrence of severe cases.

Identifiants

pubmed: 32722990
doi: 10.1080/21505594.2020.1802194
pmc: PMC7550018
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1006-1014

Références

JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
Clin Infect Dis. 2020 Nov 5;71(8):2018
pubmed: 32271372
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Med Virol. 2020 Nov;92(11):2286-2287
pubmed: 32347980
Intensive Care Med. 2020 Jun;46(6):1114-1116
pubmed: 32236644
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Ann Transl Med. 2020 Sep;8(17):1084
pubmed: 33145303
Comput Biol Med. 2023 May;158:106794
pubmed: 37044045
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Cell Res. 2020 Jun;30(6):541-543
pubmed: 32346074
J Med Virol. 2020 Oct;92(10):1755-1756
pubmed: 32270882
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Front Med (Lausanne). 2021 Jan 13;7:563893
pubmed: 33521006
Clin Microbiol Infect. 2020 Jul;26(7):957-959
pubmed: 32234453
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304

Auteurs

Chao Yu (C)

Department of Respiratory and Critical Care Medicine, Naval Hospital of Eastern Theater of PLA ,Zhoushan, Zhejiang, P. R. China.
No.5 Department of Infectious Diseases, Guanggu District, The Maternal and Child Health Hospital of Hubei Province , Wuhan, Hubei, P. R. China.

Miao Zhou (M)

Department of Anesthesiology and SICU, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University , Shanghai, P. R. China.

Yang Liu (Y)

Department of Anesthesiology, Changzheng Hospital, Second Military Medical University , Shanghai, P. R. China.

Tinglin Guo (T)

Department of Respiratory and Critical Care Medicine, Naval Hospital of Eastern Theater of PLA ,Zhoushan, Zhejiang, P. R. China.
No.5 Department of Infectious Diseases, Guanggu District, The Maternal and Child Health Hospital of Hubei Province , Wuhan, Hubei, P. R. China.

Chongyang Ou (C)

Department of Respiratory and Critical Care Medicine, Naval Hospital of Eastern Theater of PLA ,Zhoushan, Zhejiang, P. R. China.
No.5 Department of Infectious Diseases, Guanggu District, The Maternal and Child Health Hospital of Hubei Province , Wuhan, Hubei, P. R. China.

Liye Yang (L)

Department of Anesthesiology, Changzheng Hospital, Second Military Medical University , Shanghai, P. R. China.
No.2 Department of Infectious Diseases, Wuhan Huoshenshan Hospital , Wuhan, Hubei, P. R. China.

Yan Li (Y)

Department of Orthopedics, Ningxiang People's Hospital, Changsha City , Hunan, P. R. China.
Department of Tuberculosis, North Ward 5, Wuhan Jinyintan Hospital , Wuhan, Hubei, P. R. China.

Dongliang Li (D)

Department of Hepatobiliary Medicine, The 900th Hospital of the People's Liberation Army Joint Service Force , Fuzhou, Fujian, P. R. China.
No.8 Department of Infectious Diseases, Taikang Tongji (Wuhan) Hospital of Hubei Province , Wuhan, Hubei, P. R. China.

Xinyu Hu (X)

Graduate School, Hebei North University , Zhangjiakou, Hebei, P. R. China.

Li Shuai (L)

Department of Respiratory and Critical Care Medicine, Naval Hospital of Eastern Theater of PLA ,Zhoushan, Zhejiang, P. R. China.

Bin Wang (B)

Department of Oncology, Changhai Hospital, Second Military Medical University , Shanghai, P. R. China.

Zui Zou (Z)

Department of Anesthesiology, Changzheng Hospital, Second Military Medical University , Shanghai, P. R. China.
No.3 Department of Infectious Diseases, Guanggu District, The Maternal and Child Health Hospital of Hubei Province , Wuhan, Hubei, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH